DK234890A - Humant c3b/c4b-receptorgen (cr1), nucleinsyresekvenser og fragmenter deraf, deres ekspression samt proteiner og peptider kodet deraf - Google Patents

Humant c3b/c4b-receptorgen (cr1), nucleinsyresekvenser og fragmenter deraf, deres ekspression samt proteiner og peptider kodet deraf Download PDF

Info

Publication number
DK234890A
DK234890A DK234890A DK234890A DK234890A DK 234890 A DK234890 A DK 234890A DK 234890 A DK234890 A DK 234890A DK 234890 A DK234890 A DK 234890A DK 234890 A DK234890 A DK 234890A
Authority
DK
Denmark
Prior art keywords
fragments
expression
proteins
receptor
nucleic acid
Prior art date
Application number
DK234890A
Other languages
English (en)
Other versions
DK175699B1 (da
DK234890D0 (da
Inventor
Douglas T Fearon
Lloyd B Klickstein
Winnie W Wong
Gerald R Carson
Michael F Concino
Stephen H Ip
Savvas C Makrides
Jr Henry C Marsh
Original Assignee
Univ Johns Hopkins
Brigham & Womens Hospital
T Cell Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins, Brigham & Womens Hospital, T Cell Sciences Inc filed Critical Univ Johns Hopkins
Publication of DK234890D0 publication Critical patent/DK234890D0/da
Publication of DK234890A publication Critical patent/DK234890A/da
Application granted granted Critical
Publication of DK175699B1 publication Critical patent/DK175699B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153—Streptokinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Joining Of Building Structures In Genera (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK199002348A 1988-04-01 1990-09-28 Nucleinsyremolekyle, rekombinant DNA-vektor indeholdende nucleinsyremolekylet, rekombinant ekspressionsvektor indeholdende nucleinsyremolekylet, celle indeholdende nucleotidsekvensen, oplöseligt CR1-polypeptid, fremgangsmåde til fremstilling ............. DK175699B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US17653288A 1988-04-01 1988-04-01
US17653288 1988-04-01
US8901358 1989-03-31
PCT/US1989/001358 WO1989009220A1 (en) 1988-04-01 1989-03-31 THE HUMAN C3b/C4b RECEPTOR (CR1)
US41274589A 1989-09-26 1989-09-26
US41274589 1989-09-26

Publications (3)

Publication Number Publication Date
DK234890D0 DK234890D0 (da) 1990-09-28
DK234890A true DK234890A (da) 1990-11-30
DK175699B1 DK175699B1 (da) 2005-01-24

Family

ID=26872337

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199002348A DK175699B1 (da) 1988-04-01 1990-09-28 Nucleinsyremolekyle, rekombinant DNA-vektor indeholdende nucleinsyremolekylet, rekombinant ekspressionsvektor indeholdende nucleinsyremolekylet, celle indeholdende nucleotidsekvensen, oplöseligt CR1-polypeptid, fremgangsmåde til fremstilling .............

Country Status (14)

Country Link
EP (1) EP0411031B1 (da)
JP (1) JP3484189B2 (da)
CN (2) CN1092712C (da)
AT (1) ATE240973T1 (da)
CA (2) CA1341443C (da)
DE (1) DE68929466T2 (da)
DK (1) DK175699B1 (da)
ES (1) ES2014593A6 (da)
FI (2) FI106316B (da)
IL (1) IL89790A (da)
NO (1) NO315944B1 (da)
SG (1) SG52789A1 (da)
WO (1) WO1989009220A1 (da)
ZA (2) ZA892397B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
US6482404B1 (en) 1989-10-12 2002-11-19 David James White Transplantation of tissue comprising a DNA sequence encoding a homologous complement restriction factor
IE75345B1 (en) * 1989-10-12 1997-08-27 Imutran Ltd Modified biological material
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
US6458360B1 (en) * 1990-04-25 2002-10-01 The Johns Hopkins University Soluble complement regulatory molecules
CA2096418C (en) * 1990-11-26 2001-11-20 Philip J. Barr Expression of pace in host cells and methods of use thereof
AU9149791A (en) * 1990-12-06 1992-07-08 T Cell Sciences, Inc. Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity
EP0512733A2 (en) * 1991-05-03 1992-11-11 Washington University Modified complement system regulator
JP3939747B2 (ja) * 1992-06-24 2007-07-04 アドプロテック・リミテッド 可溶性ｃｒ１誘導体
US5456909A (en) * 1992-08-07 1995-10-10 T Cell Sciences, Inc. Glycoform fractions of recombinant soluble complement receptor 1 (sCR1) having extended half-lives in vivo
DE69431290D1 (de) * 1993-02-12 2002-10-10 Avant Immunotherapeutics Inc PULMONÄRE VERABREICHUNG DES LÖSLICHEN KOMPLEMENT-RECEPTORS TYP 1 sCR1
BR9708387A (pt) 1996-03-28 2000-01-04 Genitrix Llc Processo para vacinação de um mamìfero a um antìgeno selecionado, células patogênica e hospedeira, composição de vacina, ácido nucleico, e, opsonina engenheirada.
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
GB9706950D0 (en) * 1997-04-05 1997-05-21 Chernajovsky Yuti Immune modulation by polypeptides related to CR1
AU5317499A (en) * 1998-07-24 2000-02-14 Uab Research Foundation Genetic polymorphism in a complement receptor
US6664052B1 (en) 1998-07-24 2003-12-16 The Uab Research Foundation Genetic polymorphism in a complement receptor
GB9905503D0 (en) 1999-03-10 1999-05-05 Adprotech Plc Novel compound formulations and methods of delivery
EP1738763A1 (en) 2005-06-30 2007-01-03 AVANT Immunotherapeutics, Inc. Use of complement inhibitory proteins to treat spinal cord injury
PT3028716T (pt) 2006-10-10 2020-11-23 Regenesance B V Inibição do complemento para regeneração nervosa melhorada
CN102245765B (zh) 2008-10-21 2015-01-07 通用医院公司 细胞移植
CN103153376B (zh) 2010-08-06 2018-04-20 通用医院公司以麻省总医院名义经营 用于细胞处理相关应用的系统和设备
CA2811291C (en) 2010-09-15 2018-05-29 Celldex Therapeutics, Inc. Treatment of chronic nephropathies using soluble complement receptor type i (scr1)
WO2012058479A2 (en) 2010-10-27 2012-05-03 Celldex Therapeutics, Inc. Method of improving transplant function using soluble complement receptor type i (scr1)
ES2564290T3 (es) 2010-11-02 2016-03-21 Kypha, Inc. Inmunoensayo de flujo lateral para la activación de complemento y métodos de uso para evaluación del sitio de atención de trastornos asociados a complemento
CN102702339B (zh) * 2011-05-24 2013-10-30 华南师范大学 斜带石斑鱼补体c3基因、载体、重组菌株和蛋白及其应用
EP2785744B1 (en) * 2011-12-01 2017-10-04 AP Biosciences, Inc. Protein inhibitors to complement and vegf pathways and methods of use thereof
WO2013082458A1 (en) 2011-12-02 2013-06-06 The Regents Of The University Of California Reperfusion protection solution and uses thereof
CN104293836A (zh) * 2014-06-24 2015-01-21 长沙赢润生物技术有限公司 一种免疫复合物吸附细胞的制作方法
GB201800620D0 (en) 2018-01-15 2018-02-28 Univ Manchester C3b Binding Polypeptide
EP3760645A1 (en) * 2019-07-02 2021-01-06 imusyn GmbH & Co. KG Analysis for blood group antigen dacy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60192948A (ja) * 1984-03-14 1985-10-01 Fuji Photo Film Co Ltd 湿し水不要ネガ型感光性平版印刷版および製版方法
US4672044A (en) * 1984-08-24 1987-06-09 Scripps Clinic & Research Foundation Murine monoclonal antibody combining site to human C3b receptor (CR1)

Also Published As

Publication number Publication date
ZA892397B (en) 1989-11-29
IL89790A0 (en) 1989-09-28
FI115528B (fi) 2005-05-31
ATE240973T1 (de) 2003-06-15
AU3539489A (en) 1989-10-16
ZA907693B (en) 1992-05-27
DE68929466D1 (de) 2003-06-26
NO20000827D0 (no) 2000-02-18
AU647371B2 (en) 1994-03-24
EP0411031A1 (en) 1991-02-06
SG52789A1 (en) 1998-09-28
IL89790A (en) 2002-05-23
DK175699B1 (da) 2005-01-24
WO1989009220A1 (en) 1989-10-05
ES2014593A6 (es) 1990-07-16
NO20000827L (no) 1990-11-09
EP0411031A4 (en) 1992-02-05
DK234890D0 (da) 1990-09-28
FI904842A0 (fi) 1990-10-01
CN1053924C (zh) 2000-06-28
CN1053265A (zh) 1991-07-24
CN1036987A (zh) 1989-11-08
FI20002515A (fi) 2000-11-16
JP3484189B2 (ja) 2004-01-06
FI106316B (fi) 2001-01-15
CN1092712C (zh) 2002-10-16
CA1341443C (en) 2003-10-07
NO315944B1 (no) 2003-11-17
CA1340866C (en) 1999-12-28
DE68929466T2 (de) 2004-04-01
JPH04501502A (ja) 1992-03-19
EP0411031B1 (en) 2003-05-21

Similar Documents

Publication Publication Date Title
DK234890A (da) Humant c3b/c4b-receptorgen (cr1), nucleinsyresekvenser og fragmenter deraf, deres ekspression samt proteiner og peptider kodet deraf
ATE256181T1 (de) Menschlicher c3b/c4b-rezeptor (cr1)
US5401651A (en) DNA encoding ENA-78, a neutrophil activating factor
Bartsch et al. Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cells
CA2222279A1 (en) Hypoxia inducible factor-1 and method of use
FR2637612B1 (fr) Sequences de nucleotides codant pour une proteine a activite ureasique
NO177678C (no) Fremgangsmåte for fremstilling av et terapeutisk aktivt, rekombinant protein som har ASP-aktivitet, ekspresjonssystem samt DNA som koder for nevnte protein
KR970705405A (ko) 사람 케모킨 폴리펩타이드(Human Chemokine Polypeptides)
DK244289D0 (da) Fibronectinbindende protein, dets anvendelse og fremstilling samt midler til brug ved fremstillingen
NZ503235A (en) Amino-terminally truncated RANTES as chemokine antagonists
MX9203654A (es) Purificacion, clonacion y caracterizacion del gen para la interleucina i.
PT98695A (pt) Gene codificador do factor neurotrofico de ligacao a heparina
CA2202519A1 (en) Cloning, expression and characterization of a new form of phosphatidylinositol-3-kinase
DK288789A (da) Peptider og syreadditionssalte deraf, deres fremstilling og anvendelse
HUP9904500A2 (hu) Bicisztronos rekombináns adenovírus diszlipoproteinémiával összefüggő betegségek kezelésére
Adams et al. Genes encoding giant danio and golden shiner ependymin
EP0913470A3 (en) The human C3b/C4b receptor (CR1)
Lockridge Amino acid composition and sequence of human serum cholinesterase: A progress report
KR930701475A (ko) 사람의 거핵구-집락 촉진 인자(hMeg-CSF) 및 그것의 생산방법
BR0208140A (pt) Polipeptìdeo, agente imunoterapêutico para o tratamento de psorìase, sequência de ácido nucléico isolada ou seu complemento, vetores de filamento único, e de filamento duplo, sequência de ácido nucléico isolada ou variante imunogênica da mesma, métodos para a produção de polipeptìdeos, e para o tratamento e a remissão clìnica de psorìase, e, célula hospedeira microbiana
EP0502876B1 (de) Neue blutgerinnselauflösende proteine und ihre herstellung aus dem blutegel hirudo medicinalis
Kiliańska et al. Distribution of non‐histone proteins between micrococcal nuclease sensitive and nuclease resistant chromatin from chicken cells with active and inactive genomes
RU98123505A (ru) Толлоидподобный ген млекопитающих и кодируемый им протеин
TH38577A (th) การทำรหัส dna ของโปรตีนที่กระตุ้นเร่งพลาสมิโนเจน

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK